Avoro Capital Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,140,607
| Closed | -$37.4M | – | 49 |
|
|
2024
Q1 | $37.4M | Buy |
4,140,607
+990,607
| +31% | +$8.96M | 0.44% | 38 |
|
|
2023
Q4 | $34.2M | Hold |
3,150,000
| – | – | 0.47% | 29 |
|
|
2023
Q3 | $25.4M | Hold |
3,150,000
| – | – | 0.4% | 29 |
|
|
2023
Q2 | $34.2M | Hold |
3,150,000
| – | – | 0.46% | 27 |
|
|
2023
Q1 | $21.7M | Hold |
3,150,000
| – | – | 0.32% | 29 |
|
|
2022
Q4 | $12.5M | Hold |
3,150,000
| – | – | 0.19% | 33 |
|
|
2022
Q3 | $20.9M | Hold |
3,150,000
| – | – | 0.39% | 31 |
|
|
2022
Q2 | $15.2M | Hold |
3,150,000
| – | – | 0.3% | 32 |
|
|
2022
Q1 | $29.5M | Sell |
3,150,000
-85,000
| -3% | -$795K | 0.54% | 29 |
|
|
2021
Q4 | $38.4M | Hold |
3,235,000
| – | – | 0.65% | 24 |
|
|
2021
Q3 | $36.8M | Hold |
3,235,000
| – | – | 0.58% | 26 |
|
|
2021
Q2 | $58M | Hold |
3,235,000
| – | – | 1.01% | 23 |
|
|
2021
Q1 | $50.1M | Buy |
3,235,000
+2,858
| +0.1% | +$44.2K | 0.86% | 24 |
|
|
2020
Q4 | $39.4M | Buy |
3,232,142
+232,142
| +8% | +$2.83M | 0.68% | 27 |
|
|
2020
Q3 | $38.6M | Buy |
3,000,000
+10,000
| +0.3% | +$129K | 0.55% | 28 |
|
|
2020
Q2 | $30.4M | Buy |
2,990,000
+1,440,000
| +93% | +$14.6M | 0.6% | 30 |
|
|
2020
Q1 | $12.6M | Hold |
1,550,000
| – | – | 0.42% | 31 |
|
|
2019
Q4 | $13.4M | Buy |
+1,550,000
| New | +$13.4M | 0.39% | 25 |
|